Synchron Secures $40M In Series B Led By Khosla Ventures To Launch U.S. Clinical Trials Of Minimally Invasive Brain Computer Interface
Amount Raised
$40 Million
Round Type
Series B
BrooklynOtherBiotechnologyHealth CareMedical Equipment ManufacturingDescription
Synchron, a brain interface platform company, today announced that the company has secured $40M in a Series B round of financing led by Silicon Valley venture capital firm Khosla Ventures. Synchron is the leader in minimally invasive implantable brain computer interface (BCI) technology, which utilizes the jugular vein to access the brain. Synchron has already commenced a clinical trial in Australia that has so far enrolled four patients with paralysis who have undergone implantation and are being assessed for their ability to control digital devices through thought to improve their functional independence.
Quick answer
Synchron raised $40 Million in a Series B round, dated June 3, 2021. Synchron is based in Brooklyn, New York, United States.
- How much did Synchron raise?
- Synchron raised $40 Million in a Series B round on June 3, 2021.
- What does Synchron do?
- Synchron is developing implantable neurotechnology to unlock the brain and solve unmet medical needs at scale
- Where is Synchron based and how big is it?
- Synchron is based in Brooklyn, New York, United States. Fundz records about 127 employees.
- Who are the decision-makers at Synchron?
- Fundz holds 2 contacts at Synchron. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical Equipment Manufacturing and Biotechnology around the same time
Companies in the same sectors as Synchron that raised within 45 days of this round, from Fundz verified event records.
- Tellus Therapeutics raised $2M (Seed) on July 16, 2021.
- OM1 raised $85M on July 16, 2021.
- OM1 raised $85M (Funding Round) on July 16, 2021.
- SynerFuse, Inc. raised $275K (Seed) on July 15, 2021.
- Tenon Medical raised $12M on July 15, 2021.
- Telo Genomics raised $81K (Pre-Seed) on July 15, 2021.
Who to call at Synchron, and when
A new round usually means Synchron is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Synchron raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Synchron, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Synchron. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Synchron raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSynchron raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.